PRACTICE NOTE 17 / GUIDANCE NOTE 3 : MONTHLY ANNOUNCEMENT
| PHARMANIAGA BERHAD |
| Type | Announcement |
| Subject | PRACTICE NOTE 17 / GUIDANCE NOTE 3 MONTHLY ANNOUNCEMENT |
| Description | PHARMANIAGA BERHAD (THE "COMPANY") - MONTHLY ANNOUNCEMENT PURSUANT TO PRACTICE NOTE 17 OF THE MAIN MARKET LISTING REQUIREMENTS OF BURSA MALAYSIA SECURITIES BERHAD |
|
Reference is made to the Company's First Announcement dated 27 February 2023 as well as the subsequent announcements in relation to the Regularisation Plan ("Previous Announcements"). (Unless otherwise stated, the words and abbreviations used herein shall have the same meaning as those defined in the Previous Announcements.) The Company wishes to announce that, there have been no other material developments since the announcement made on 6 August 2025. This announcement is dated 4 November 2025.
|
|
Announcement Info
| Company Name | PHARMANIAGA BERHAD |
| Stock Name | PHARMA |
| Date Announced | 04 Nov 2025 |
| Category | General Announcement for PLC |
| Reference Number | GA1-30102025-00008 |